Aequus Pharmaceuticals Inc banner

Aequus Pharmaceuticals Inc
F:AEQ

Watchlist Manager
Aequus Pharmaceuticals Inc Logo
Aequus Pharmaceuticals Inc
F:AEQ
Watchlist
Price: 0.049 EUR Market Closed
Market Cap: €6.5m

Wall St Price Targets

AEQ Price Targets Summary
Aequus Pharmaceuticals Inc

There are no price targets for AEQ.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Aequus Pharmaceuticals Inc Competitors:
Price Targets
OFN
Orell Fuessli AG
-6% Downside
JEF
Jefferies Financial Group Inc
19% Upside

Revenue
Forecast

N/A
Past Growth
-18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 9 years is -18%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Aequus Pharmaceuticals Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AEQ's stock price target?
Not Available

AEQ does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Aequus Pharmaceuticals Inc?
Projected CAGR
-18%

The compound annual growth rate for Revenue over the next 9 years is -18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett